Page last updated: 2024-09-05

ocinaplon and Anxiety Neuroses

ocinaplon has been researched along with Anxiety Neuroses in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beer, B; Czobor, P; Lippa, A; Skolnick, P	1
Bandyopadhyay, S; Beer, B; Czobor, P; Farb, DH; Gibbs, TT; Gravielle, M; Kostakis, E; Lippa, A; Russek, SJ; Skolnick, P; Stark, J	1

Trials

2 trial(s) available for ocinaplon and Anxiety Neuroses

Article	Year
A multicenter, placebo-controlled, double-blind, randomized study of efficacy and safety of ocinaplon (DOV 273,547) in generalized anxiety disorder. CNS neuroscience & therapeutics, 2010, Volume: 16, Issue:2 Topics: Adolescent; Adult; Anti-Anxiety Agents; Anxiety Disorders; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Models, Statistical; Psychiatric Status Rating Scales; Pyrimidines; Treatment Outcome; Young Adult	2010
Selective anxiolysis produced by ocinaplon, a GABA(A) receptor modulator. Proceedings of the National Academy of Sciences of the United States of America, 2005, May-17, Volume: 102, Issue:20 Topics: Adult; Animals; Anti-Anxiety Agents; Anticonvulsants; Anxiety Disorders; Behavior, Animal; Conditioning, Operant; Diazepam; Double-Blind Method; Flunitrazepam; Germany; Humans; Oocytes; Patch-Clamp Techniques; Pentylenetetrazole; Pyrimidines; Rats; Receptors, GABA-A; Saimiri; Tritium; Xenopus laevis	2005

Article

Year

A multicenter, placebo-controlled, double-blind, randomized study of efficacy and safety of ocinaplon (DOV 273,547) in generalized anxiety disorder.

CNS neuroscience & therapeutics, 2010, Volume: 16, Issue:2

Topics: Adolescent; Adult; Anti-Anxiety Agents; Anxiety Disorders; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Models, Statistical; Psychiatric Status Rating Scales; Pyrimidines; Treatment Outcome; Young Adult

2010

Selective anxiolysis produced by ocinaplon, a GABA(A) receptor modulator.

Proceedings of the National Academy of Sciences of the United States of America, 2005, May-17, Volume: 102, Issue:20

Topics: Adult; Animals; Anti-Anxiety Agents; Anticonvulsants; Anxiety Disorders; Behavior, Animal; Conditioning, Operant; Diazepam; Double-Blind Method; Flunitrazepam; Germany; Humans; Oocytes; Patch-Clamp Techniques; Pentylenetetrazole; Pyrimidines; Rats; Receptors, GABA-A; Saimiri; Tritium; Xenopus laevis

2005